{"title":"亨廷顿氏病的电休克疗法","authors":"A. Yahya, Shakil Khawaja","doi":"10.1002/pnp.729","DOIUrl":null,"url":null,"abstract":"Electroconvulsive therapy (ECT) is used in Huntington's disease (HD) for severe and life threatening forms of mental illness when other treatment options have failed or when a rapid response is required. Here, Dr Yahya and Dr Khawaja review the published literature over the last 10 years for the use of ECT in HD focusing on efficacy, safety and tolerability.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electroconvulsive therapy in Huntington's disease\",\"authors\":\"A. Yahya, Shakil Khawaja\",\"doi\":\"10.1002/pnp.729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Electroconvulsive therapy (ECT) is used in Huntington's disease (HD) for severe and life threatening forms of mental illness when other treatment options have failed or when a rapid response is required. Here, Dr Yahya and Dr Khawaja review the published literature over the last 10 years for the use of ECT in HD focusing on efficacy, safety and tolerability.\",\"PeriodicalId\":43913,\"journal\":{\"name\":\"Progress in Neurology and Psychiatry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pnp.729\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pnp.729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Electroconvulsive therapy (ECT) is used in Huntington's disease (HD) for severe and life threatening forms of mental illness when other treatment options have failed or when a rapid response is required. Here, Dr Yahya and Dr Khawaja review the published literature over the last 10 years for the use of ECT in HD focusing on efficacy, safety and tolerability.
期刊介绍:
Progress in Neurology and Psychiatry is published nine times a year, and is a journal for specialists in secondary care, GPs with an interest in neurology and psychiatry, community psychiatric nurses and other specialist healthcare professionals. Articles cover management, news updates and opinion in all areas of neurology and psychiatry.